Loading company…
XORI Corporation develops a platform for discovering and developing monoclonal antibodies.
XORI Corporation develops a platform for the discovery and development of monoclonal antibodies, with potential applications in infectious diseases, immune disorders, and cancer. Founded in 2009, the company is based in Seattle, US, and is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in